Topline: South Africa’s Department of Health has indicated that the process to roll out the SARS-COV-2 vaccine will start this month. A million doses of the vaccine will come from the Serum Institute of India (SII).
Key Facts
In addition to the million, the department has stated that they will also get 500,000 doses from the SII in February.
South African Health Minister, Dr. Zweli Mkhize, said in a statement on Thursday that the government will be prioritizing health workers by ensuring that they receive the vaccine by February.
South Africa has entered the second wave of the pandemic, reporting over 20,000 new cases on Wednesday, January 6.
As of today, the total number of confirmed #COVID19 cases is 1 149 591, the total number of deaths is 31 368 and the total number of recoveries is 929 239. pic.twitter.com/ceWOvUlWyw
The department has been in talks with the SII but could not disclose any details regarding the deal with the institute for the Oxford University-AstraZeneca vaccines.
When briefing Parliament’s Portfolio Committee on Thursday morning, Mkihze further said that the department did approach several vaccine manufacturers and discussions are at a “sensitive stage” and believes those talks to be concluded very soon.
It is still unclear the exact dates when South Africa will receive these vaccines and when they will be rolled out to the public.
What has been made clear, however, is that medical schemes and the government have come up with a plan that will cover the vaccination against the virus, according toRadio 702.
“It’s mandatory for medical schemes to pay for the Covid-19 vaccine,” Dr Ryan Noach, CEO at Discovery Health, on Radio 702.
In addition to this, President Cyril Ramaphosa tweeted on Wednesday that Canada may share any excess stock with South Africa.
Canada has committed to sharing any excess pre-purchase orders with countries in need once supplies are available, and to influence other countries to act in the interests of multilateralism to defeat the virus in the spirit of security and safety for all.
“We are happy that the SII/Astra Zeneca vaccine has already been approved by various regulators and is being rolled out in other countries. Therefore, as part of expediting the regulatory process, the South African Health Products Regulatory Authority (SAHPRA) is applying reliance on that regulatory work,” said Mkhize in his statement on Thursday.
Get the best of Forbes Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.
